OPKO Health, Inc. Sustainability Profile
OPKO Health, Inc., a prominent player in the biotechnology and diagnostics industry, is headquartered in the United States. Founded in 2007, the company has rapidly evolved, focusing on innovative solutions in pharmaceuticals, diagnostics, and laboratory services. OPKO is particularly known for its cutting-edge products, including the 4Kscore® test for prostate cancer and its proprietary growth hormone therapies, which set it apart in the competitive healthcare landscape. With a strong presence in the US and expanding operations in international markets, OPKO Health has achieved significant milestones, including strategic partnerships and acquisitions that enhance its product offerings. The company’s commitment to advancing healthcare through research and development has solidified its position as a leader in the industry, making it a key player in the ongoing evolution of medical diagnostics and therapeutics.
DitchCarbon Score
How does OPKO Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OPKO Health, Inc.'s score of 25 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OPKO Health, Inc.'s reported carbon emissions
OPKO Health, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions. In the absence of concrete emissions data or reduction commitments, it is unclear how OPKO Health, Inc. is addressing climate change or its carbon emissions. The company may need to enhance its transparency and reporting on environmental impacts to align with industry standards and stakeholder expectations.
How Carbon Intensive is OPKO Health, Inc.'s Industry?
How Carbon Intensive is OPKO Health, Inc.'s Location?
OPKO Health, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OPKO Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
